Clinical Trial Update: Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis C [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating peginterferon alfa-2a plus ribavirin for chronic hepatitis B and hepatitis C co-infection and chronic hepatitis C; the study s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Hepatitis C

Drugs mentioned

• Peginterferon alfa-2a (peginterferon alfa-2a)
• Ribavirin (ribavirin)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Hepatitis B, Chronic, Hepatitis C, Chronic | Phase 3 | Status: UNKNOWN